Keywords: novartis, files, estradot, eu, applied, marketing, authorization

Novartis files Estradot in the EU

Article | 07 August 2001

Print This

Novartis has applied for marketing authorization for Estradot(transdermal 17-beta estradiol) in the European Union.

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in